An investigation on behalf of investors in ImmuCell Corporation (NASDAQ:ICCC) shares over potential wrongdoing at ImmuCell Corporation was announced and NASDAQ:ICCC stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 04/20/2017 -- An investigation on behalf of investors in NASDAQ:ICCC shares was announced over possible breaches of fiduciary duties by certain ImmuCell Corporation directors.
Investors who purchased shares of ImmuCell Corporation (NASDAQ:ICCC) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.
The investigation by a law firm concerns whether certain ImmuCell officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
ImmuCell Corporation reported that its annual Total Revenue declined from $10.23 million in 2015 to $9.54 million in 2016. Shares of ImmuCell Corporation (NASDAQ:ICCC) declined from $11.00 per share in July 2015 to as low as $4.90 per share in November 2016.
On April 19, 2017, NASDAQ:ICCC shares closed at $5.32 per share.
Those who purchased shares of ImmuCell Corporation have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com